STShigeo Takaishi

Shigeo Takaishi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shigeo Takaishi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Aiko Sugiyama

    DSK Project, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    1 shared publication
  • Akihiko Yoshizawa

    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan

    1 shared publication
  • Akitada Yogo

    DSK Project, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    1 shared publication
  • Hiroshi Seno

    DSK Project, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    1 shared publication
  • Kenji Masuo

    DSK Project, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    1 shared publication
  • Ru Chen

    DSK Project, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    1 shared publication

Latest Publications

  • SNAIL regulates gastric carcinogenesis through CCN3 and NEFL

    by Ru Chen, Kenji Masuo, Akitada Yogo, Shoko Yokoyama, Aiko Sugiyama, Hiroshi Seno, Akihiko Yoshizawa, Shigeo Takaishi

    Among cancer cells, there are specific cell populations of whose activities are comparable to those of stem cells in normal tissues, and for whom the levels of cell dedifferentiation are reported to correlate with poor prognosis. Information concerning the mechanisms that modulate the stemness like traits of cancer cells is limited. Therefore, we examined five gastric cancer cell lines and isolated gastric oncospheres from three gastric cancer cell lines. The gastric cancer cells that expanded in the spheres expressed relatively elevated proportion of CD44, which is a marker of gastric cancer stem cells (CSCs), and displayed many properties of CSCs, for example: chemoresistance, tumorigenicity and epithelial–mesenchymal transition (EMT) acquisition. SNAIL, which is a key factor in EMT, was highly expressed in the gastric spheres. Microarray analysis in gastric cancer cell line HGC27 showed that CCN3 and NEFL displayed the greatest differential expression by knocking down of SNAIL; the former was upregulated and the latter downregulated, respectively. Downregulation of CCN3 and upregulation of NEFL gene expression impaired the SNAIL-dependent EMT activity: high tumorigenicity, and chemoresistance in gastric cancer cells. Thus, approach that disrupts SNAIL/CCN3/NEFL axis may be credible in inhibiting gastric cancer development.